Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients

Summary Outcomes for melanoma patients with stage III disease differ widely even within the same subcategory. Molecular signatures that more accurately predict prognosis are needed to stratify patients according to risk. Proteomic analyses were used to identify differentially abundant proteins in ex...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pigment cell and melanoma research 2014-11, Vol.27 (6), p.1106-1116
Hauptverfasser:	Mactier, Swetlana, Kaufman, Kimberley L., Wang, Penghao, Crossett, Ben, Pupo, Gulietta M., Kohnke, Philippa L., Thompson, John F., Scolyer, Richard A., Yang, Jean Y., Mann, Graham J., Christopherson, Richard I.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cluster Analysis DIGE Electrophoresis, Gel, Two-Dimensional Gene Regulatory Networks Humans Isotope Labeling iTRAQ 2DLC-MS/MS Kaplan-Meier Estimate lymph node metastasis melanoma Melanoma - metabolism Melanoma - pathology Neoplasm Proteins - metabolism Neoplasm Staging Original prognosis protein markers Reproducibility of Results Skin Neoplasms - metabolism Skin Neoplasms - pathology SRM Tandem Mass Spectrometry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!